Market Tracker

08/20 4:25pm ET

SPDR S&P Pharmaceuticals ETF (XPH)

100.79
Data as of 4:00pm ET
 -0.3328 / -0.33%
Today’s Change
74.15
Today|||52-Week Range
106.76
+14.57%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+1.07% 3 years+34.28%
3 months+5.38% 5 years+27.36%
1 year+38.13% Since inception+16.96%
Data through 08/20/2014

Quote Details

Previous close$101.12
Open day’s range100.20 – 101.11
Net asset value (NAV)100.96 (08/19/2014)
Daily volume107,285
Average volume (3 months)87,252
Data as of 4:00pm ET, 08/20/2014

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+27.36%+24.14%
Expense Gross exp ratio0.35%0.43%
Risk 5 year sharpe ratio1.641.41
Net assets$842.2M$1.3B
Average market cap$8.2B$28.6B
Average P/E29.125.7
Dividend / Share--0.21%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AKRX Akorn Inc4.21%
SLXP Salix Pharmaceuticals Ltd4.05%
PCRX Pacira Pharmaceuticals Inc3.86%
HSP Hospira Inc3.76%
BMY Bristol-Myers Squibb Company3.70%
PRGO Perrigo Co PLC3.69%
LLY Eli Lilly and Co3.57%
AGN Allergan Inc3.53%
ACT Actavis PLC3.53%
ZTS Zoetis Inc3.53%